Citations 2
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares
Krueger, James G. , Sarkar, Mrinal K. , Lebwohl, Mark , Gordon, Kenneth B. , Bogle, Rachael , Cole, C. , Coon, Anthony, Burden, A. David , Zheng, Min , Mangold, Aaron R. , Anadkat, Milan J. , Barker, Jonathan N., Tang, Ming , Becker, Kolja , Delić, Denis , Thoma, Christian , Mangold, A R , Sarkar, Mrinal K , Morita, Akimichi , Wasikowski, Rachael, Langley, Richard G B , Warren, Richard Bruce , Mostaghimi, Arash , Strober, Bruce E , Barker, Jonathan N., Merola, Joseph F. , Tsoi, Lam C. , Gudjonsson, Johann E
Journal of Clinical Investigation | July 1, 2025 | Volume: 135 | Issue: 17 | Pages: No page available
S930 Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years
Long, Millie D. , Ott, Elyssa , Gasink, Christopher , Ye, Miao , Baker, Thomas, Tikhonov, Ilia , Rahman, Proton , Danese, Silvio , Strober, Bruce E , Loftus, Edward V.
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S441-S441